Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global market revenue for the renal function test market is anticipated to reach US$ 1,494.1 million by 2033, with a 5.5% CAGR during the forecast period. As of 2023, the renal function test market is valued at US$ 871.3 million.
Key Market Highlights
Growing Prevalence of Diabetes and Hypertension Boosts Renal Function Test Market
Renal function test refers to a series of blood and urine tests that help doctors understand the condition of patients' kidneys. In these few decades, cardiovascular disease has tremendously increased due to a passive lifestyle, alcohol abuse, and unhealthy eating habits. These diseases are the leading causes of chronic kidney diseases, which require regular monitoring of kidney functions, which is done by renal function tests.
According to the World Health Organization, around 422 million people worldwide have diabetes, and more than one billion people suffer from problems related to hypertension. As these numbers continue and are expected to grow, a rising demand for renal function tests can be seen in the upcoming years.
Digital Urinalysis at Home to Contribute Significantly to Kidney Assessment Tests
Advancements in renal function test technologies have enabled patients suffering from chronic kidney disease (CKD) to take regular tests at home. This technology may simplify the process and drive more revenue globally for the renal function test market.
Patients can now cut long lines and hefty consultation fees in public hospitals. The test results can even be accessed by the concerned medical practitioner, who can assess and proceed further with the treatment.
Attributes | Key Statistics |
---|---|
Expected Base Year Value (2023) | US$ 871.3 million |
Anticipated Forecast Value (2033) | US$ 1,494.1 million |
Estimated Growth (2023 to 2033) | 5.5% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market recorded a growth of 5.7% from 2017 to 2022 due to the increased risk of kidney diseases among the aging population. The market registered a valuation of US$ 623.6 million in 2017 and reached US$ 824.2 million in 2022.
Attributes | Key Statistics |
---|---|
Expected Base Year Value (2017) | US$ 623.6 million |
Anticipated Forecast Value (2022) | US$ 842.2 million |
Estimated Growth (2017 to 2022) | 5.7% CAGR |
When it comes to age, older people are more likely to undergo renal function tests as they require frequent testing due to the increased risk of kidney diseases. There are relatively few cases of kidney assessments being done on newborn babies and young children.
Availability and accessibility are crucial in the renal function test market. Areas with medium to low medical facilities showcase have very little influence on the market, while regions with highly advanced medical facilities are likely to have higher consumption rates of renal function tests. These factors led to the growth of RFT in the historical period.
Gender-wise, it has been observed that males contribute significantly to the renal function test market, mainly due to their association with an unhealthy lifestyle. Moreover, the growth of telemedicine services like digital urinalysis has increased awareness regarding preventive health care measures. Thus, the demand for renal function tests has surged remarkably.
Future Market Insights (FMI) has compared two other markets, the cystatin C testing market and the urine monitoring systems market. The tables showcase each market’s estimated growth performance from 2023 to 2033. It highlights that the urine monitoring systems market is expanding at a higher CAGR than the other two. However, the renal function test market signifies a greater revenue potential over the other mentioned markets.
Renal Function Test Market:
Attributes | Renal Function Test Market |
---|---|
CAGR (2023 to 2033) | 5.5% CAGR |
Market Value (2023) | US$ 871.3 million |
Growth Factors |
|
Future Opportunities |
|
Cystatin C Testing Market:
Attributes | Cystatin C Testing Market |
---|---|
CAGR (2022 to 2032) | 7.5% CAGR |
Market Value (2021) | US$ 194.3 million |
Growth Factors |
|
Future Opportunities |
|
Urine Monitoring Systems Market:
Attributes | Urine Monitoring Systems Market |
---|---|
CAGR (2023 to 2033) | 9.2% CAGR |
Market Value (2023) | US$ 571.55 million |
Growth Factors |
|
Future Opportunities |
|
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Category-wise, the renal function test market is divided into dipsticks, disposables, and reagents. The dipstick renal function test, which dominates the segment with a revenue share of 57.4%, is a simple and very commonly used renal test to monitor kidney functions. It is the most commonly used renal test and is considered to provide quick results, sometimes within minutes after the test.
Attributes | Details |
---|---|
By Product Type | Dipsticks |
Market share | 57.4% |
While renal function tests are often regarded as cost-intensive, urinalysis using dipsticks is generally more affordable and more accessible to the general population. These tests are very simple, making them very reassuring for patients who avoid long medical procedures. The infrastructure requirements for dipstick renal function tests are minimal and can be set up with a meager investment.
A renal function test using a dipstick can be the first step in assessing the overall functionality of the kidneys. Apart from kidneys, they also provide very brief information about urinal health and the amount of certain essential nutrients in the blood. Although dipstick renal tests help medical practitioners understand the overall renal information, the results are only nominal and not very precise.
Urine-based renal examinations are the most common practice used by the majority of laboratories, as they are trusted to be the most reliable test to assess urinal health. It holds a global market share of 62.4% and is found to provide quick results at affordable prices.
Attributes | Details |
---|---|
By Test Type | Urine |
Market share | 62.4% |
These tests are recommended as a regular practice and are not just limited to renal health but also consist of the functionality of the urinary tract, kidneys, and other excretory organs. Urine-based tests don't require drawing blood from the patient's body parts, making this a preferable choice for individuals intimidated by syringes and blood.
It's the easiest way to collect samples; patients can do that alone. Urine-based tests can be easily incorporated into routine check-ups. The ease of sample collection, simple setup, and broad spectrum of information can help urine-based renal tests gain impetus in the upcoming years.
The renal function test market is segmented by end-use into hospitals and clinics, diagnostic laboratories, research laboratories and institutes, and home care settings. As hospitals provide more holistic care in terms of renal tests, they dominate this segment by holding a global market share of 50.6%.
Attributes | Details |
---|---|
By End User | Hospitals and Clinics |
Market share | 50.6% |
Hospitals are packed with modern medical facilities and skilled lab technicians who can conduct simultaneous tests in the same vicinity. This makes conducting complex medicinal examinations like renal function tests very feasible. Hospitals can also provide in-house treatment facilities for patients requiring inpatient care and monitoring.
Passive urban lifestyles with little to no exercise, alcohol abuse, and unhealthy eating habits contribute to kidney dysfunction. According to a survey conducted by Future Market Insights, the North American renal function testing market recorded a market share of 34.3% in 2022.
Region | North America |
---|---|
Value Share in 2022 | 34.3% |
As one in three individuals living in this belt has diabetes, the possibility of them getting diagnosed with CKD is very high. As individuals with chronic kidney disorders require intense care and monitoring of their renal health, the demand for such facilities is touching the skies in this region.
Technological advancements in the medical facilities of several European countries have largely contributed to the growth of the global renal function market. Of the total market, Europe holds a market share of 29.8%.
Region | Europe |
---|---|
Value Share in 2022 | 29.8% |
Government initiatives coupled with health-literate residents are some of the main factors in this promising market size. For instance, Atlas Medical, a diagnostic kit manufacturer based in the United Kingdom, introduced products in blood grouping reagents, urine reagent strips, latex kits, and other home test kits.
According to the Centers for Disease Control, more than 37 million citizens of the United States have chronic kidney disorders; it is estimated that 90% of them don't even know they have it. The government bodies' CKD Initiative is shaped to collaborate with the leading hospitals, colleges, and national organizations to promote early diagnosis and reduce the risk factors by detecting the symptoms in the initial stages of the disorder.
Country | The United States |
---|---|
Value Share in 2022 | 28.8% |
The increasing geriatric population coupled with highly affluent residents makes China one of the most influential markets in renal function tests. As a country with a huge population, the demand for renal function tests may drastically boost the market size. Like most developed countries, the Chinese government has made huge investments in the research and promotion of CKDs.
Country | China |
---|---|
Value Share in 2022 | 7.4% |
Many start-up and established companies are bringing innovative medical devices that can ease the process of urine and blood tests to check the health of kidneys.
Several visionaries are at the forefront of delivering accurate results while maintaining transparency. F. Hoffmann-La Roche Ltd., Nova Biomedical, Quest Diagnostics, and ACON Laboratories are some business leaders dominating the renal function test market.
Recent Developments in the Renal Function Test Market
The current market valuation of renal function tests is likely to be US$ 871.3 million.
North America is expected to accumulate 34.3% of the market share in 2022.
The renal function test market is expected to reach US$ 1,494.1 million
Urine-based renal tests are the widely preferred segment.
The market recorded a valuation of US$ 824.2 million in 2022.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Dipsticks 5.3.2. Disposable 5.3.3. Reagents 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033 6.3.1. Urine Test 6.3.1.1. Urine Protein 6.3.1.2. Microalbumin 6.3.1.3. Creatinine Clearance 6.3.2. Blood Test 6.3.2.1. Serum Creatinine 6.3.2.2. GFR rate 6.3.2.3. Blood Urea Nitrogen (BUN) 6.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis by End User, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by End User, 2023 to 2033 7.3.1. Hospitals and Clinics 7.3.2. Diagnostic laboratories 7.3.3. Research Laboratories and Institutes 7.3.4. Home Care Settings 7.4. Y-o-Y Growth Trend Analysis by End User, 2018 to 2022 7.5. Absolute $ Opportunity Analysis by End User, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Test Type 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Test Type 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Test Type 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Test Type 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Test Type 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Test Type 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Test Type 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Test Type 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product Type 13.2.3. By Test Type 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Test Type 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Test Type 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Test Type 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Test Type 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Test Type 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Test Type 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Test Type 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Test Type 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Test Type 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Test Type 16.5.2.3. By End User 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Test Type 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Test Type 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Test Type 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Test Type 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Test Type 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Test Type 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Test Type 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Test Type 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Test Type 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Test Type 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Test Type 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Test Type 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Test Type 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Test Type 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Test Type 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product Type 16.21.2.2. By Test Type 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product Type 16.22.2.2. By Test Type 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product Type 16.23.2.2. By Test Type 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Test Type 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. F. Hoffmann-La Roche Ltd. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Siemens Healthineers 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Beckman Coulter (Danaher) 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Abbott Laboratories 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Baxter International 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Quest Diagnostic Incorporated 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Sysmex Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Laboratory Corporation of America Holdings (LabCorp) 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Randox Laboratories 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. ACON Laboratories 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Arkray 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Nova Biomedical 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Idexx Laboratories 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Opti Medicals 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.15. Elektronika 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 18.1.16. Cook Medical 18.1.16.1. Overview 18.1.16.2. Product Portfolio 18.1.16.3. Profitability by Market Segments 18.1.16.4. Sales Footprint 18.1.16.5. Strategy Overview 18.1.16.5.1. Marketing Strategy 18.1.17. VedaLab 18.1.17.1. Overview 18.1.17.2. Product Portfolio 18.1.17.3. Profitability by Market Segments 18.1.17.4. Sales Footprint 18.1.17.5. Strategy Overview 18.1.17.5.1. Marketing Strategy 18.1.18. Dx Gern Corp 18.1.18.1. Overview 18.1.18.2. Product Portfolio 18.1.18.3. Profitability by Market Segments 18.1.18.4. Sales Footprint 18.1.18.5. Strategy Overview 18.1.18.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Western Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 15: Western Europe Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 16: Western Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: Eastern Europe Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 19: Eastern Europe Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 20: Eastern Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: East Asia Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 27: East Asia Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 28: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Product Type, 2018 to 2033 Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2018 to 2033 Table 32: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 17: Global Market Attractiveness by Product Type, 2023 to 2033 Figure 18: Global Market Attractiveness by Test Type, 2023 to 2033 Figure 19: Global Market Attractiveness by End User, 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 37: North America Market Attractiveness by Product Type, 2023 to 2033 Figure 38: North America Market Attractiveness by Test Type, 2023 to 2033 Figure 39: North America Market Attractiveness by End User, 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 57: Latin America Market Attractiveness by Product Type, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Test Type, 2023 to 2033 Figure 59: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Western Europe Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 62: Western Europe Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 63: Western Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 64: Western Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Western Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 71: Western Europe Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 74: Western Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 75: Western Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 77: Western Europe Market Attractiveness by Product Type, 2023 to 2033 Figure 78: Western Europe Market Attractiveness by Test Type, 2023 to 2033 Figure 79: Western Europe Market Attractiveness by End User, 2023 to 2033 Figure 80: Western Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: Eastern Europe Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 82: Eastern Europe Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 83: Eastern Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 94: Eastern Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 97: Eastern Europe Market Attractiveness by Product Type, 2023 to 2033 Figure 98: Eastern Europe Market Attractiveness by Test Type, 2023 to 2033 Figure 99: Eastern Europe Market Attractiveness by End User, 2023 to 2033 Figure 100: Eastern Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: South Asia and Pacific Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 102: South Asia and Pacific Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 103: South Asia and Pacific Market Value (US$ Million) by End User, 2023 to 2033 Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 117: South Asia and Pacific Market Attractiveness by Product Type, 2023 to 2033 Figure 118: South Asia and Pacific Market Attractiveness by Test Type, 2023 to 2033 Figure 119: South Asia and Pacific Market Attractiveness by End User, 2023 to 2033 Figure 120: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033 Figure 121: East Asia Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 122: East Asia Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 123: East Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 124: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: East Asia Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 129: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 131: East Asia Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 132: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 134: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 135: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 136: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 137: East Asia Market Attractiveness by Product Type, 2023 to 2033 Figure 138: East Asia Market Attractiveness by Test Type, 2023 to 2033 Figure 139: East Asia Market Attractiveness by End User, 2023 to 2033 Figure 140: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 141: Middle East and Africa Market Value (US$ Million) by Product Type, 2023 to 2033 Figure 142: Middle East and Africa Market Value (US$ Million) by Test Type, 2023 to 2033 Figure 143: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033 Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033 Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Product Type, 2018 to 2033 Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2018 to 2033 Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2023 to 2033 Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2023 to 2033 Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 157: Middle East and Africa Market Attractiveness by Product Type, 2023 to 2033 Figure 158: Middle East and Africa Market Attractiveness by Test Type, 2023 to 2033 Figure 159: Middle East and Africa Market Attractiveness by End User, 2023 to 2033 Figure 160: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports